MedPath

VIVUS LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

Phase 2
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2007-06-14
Last Posted Date
2012-09-10
Lead Sponsor
VIVUS LLC
Target Recruit Count
210
Registration Number
NCT00486291
Locations
🇺🇸

Research Site, Richmond, Virginia, United States

Topical Alprostadil for Female Sexual Arousal Disorder

Phase 2
Completed
Conditions
Sexual Dysfunction, Physiological
First Posted Date
2006-05-11
Last Posted Date
2009-03-10
Lead Sponsor
VIVUS LLC
Target Recruit Count
300
Registration Number
NCT00324948
Locations
🇺🇸

Stanford University School of Medicine-Dept of OB/GYN, Stanford, California, United States

🇺🇸

Radiant Research, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath